Lyaxome tests appetite for high-end Korean beauty devices

As Korean home beauty devices gain popularity overseas, emerging brand Lyaxome is seeking a foothold in the increasingly competitive market with a premium-priced device combining multiple skincare functions. Developed by K Kin, a brand operated by Culture & Commerce, the device combines ultrasound and radiofrequency technology in a single treatment head, alongside ampoules containing exosome-based ingredients. Exosomes in skincare are tiny, membrane-bound cellular "messengers," or extracellular

2026-10-15 11:21:39:00

Wemade’s 920 billion won sell-off pushed back to December

The planned 920 billion won ($688 million) takeover of Wemade has been delayed by two months after a consortium backed by Chinese game company Kingnet postponed payment of the remaining 828 billion won. According to Wemade's regulatory filing on Wednesday, the scheduled closing date for the sale of shares held by Chairman Park Kwan-ho had been pushed back to December 30 from October 30. Under the deal signed on June 30 this year, Park agreed to sell his entire stake in Wemade -- 13.35 million sh

2026-10-14 21:52:49:00

SK Group mulls multi-billion-dollar investment in Westinghouse stake

SK Group is considering a strategic investment in US nuclear power giant Westinghouse Electric through a consortium with other Korean companies, according to reports Wednesday. Samsung C&T, Hyundai Engineering & Construction, and Doosan Enerbility are among the Korean companies reportedly considering joining a consortium being led by SK. The potential investment comes after Seoul and Washington agreed that up to $120 billion of Korea's $200 billion investment fund would be used to build eight la

2026-10-14 20:18:55:00

Father detained after allegedly beating 2-month-old daughter to death

A father in his 40s has been detained on suspicion of beating his 2-month-old daughter to death after becoming angry when she would not sleep, police said Wednesday. The Suwon District Court issued an arrest warrant for the man on charges of child abuse resulting in death, citing concerns that the suspect could flee or destroy evidence. As the suspect left Yongin Dongbu Police Station at around 8:30 a.m. that day to attend the warrant hearing, he said, "I'm sorry" when reporters asked whether he

2026-10-14 19:51:29:00

Wegovy seeks insurance edge in Korea's obesity drug war

Competition in Korea's obesity drug market is intensifying. Novo Nordisk seeks national health insurance coverage for Wegovy, aiming to regain ground against Eli Lilly's market-leading Mounjaro before Hanmi Pharmaceutical launches its newly approved homegrown rival, Eppe. Novo Nordisk Korea applied to the Health Insurance Review and Assessment Service for reimbursement of Wegovy, pharmaceutical industry sources said Tuesday. The move could significantly lower treatment costs. Since its Korean la

2026-10-13 14:23:58:00

Kim Dong-seon bets W128.5b on Hanwha M&S

Hanwha President Kim Dong-seon is putting 128.5 billion won ($96.3 million) of his own money into a tender offer for a 19 percent stake in Hanwha Machinery & Service Holdings, offering a 32 percent premium in a move that would make him the company’s largest individual shareholder. Kim, the youngest son of Hanwha Group Chair Kim Seung-youn and head of future strategy at Hanwha M&S, will offer 8,000 won per share for up to 16.06 million shares from Monday through Nov. 2, the company said. If fully

2026-10-12 14:32:40:00

Celltrion posts first W500b quarterly operating profit

Celltrion broke the 500 billion won ($374 million) quarterly operating profit mark for the first time in the third quarter, as high-margin biosimilars and lower costs powered another record performance. According to Celltrion on Monday, it posted preliminary consolidated revenue of 1.5 trillion won and operating profit of 510 billion won for the July-to-September period, up 45.8 percent and 69.2 percent, respectively, from a year earlier, marking record-high earnings for the third consecutive qu

2026-10-12 11:27:25:00

[팟캐스트] (821) 만 2세 미만 아동의 스마트폰 사용률은?

진행자: 간형우, Chelsea Proctor More toddlers under 2 start to use smartphones 기사 요약: 정부 조사에 따르면 5세 미만 아동의 절반 이상이 만 2세가 되기 전에 스마트폰을 사용하기 시작했으며, 어머니의 스마트폰 사용량이 많을수록 자녀도 더 이른 나이에 스마트폰을 접하는 경향이 나타났다. [1] More than half of children under five began using smartphones before turning two, according to a government survey. survey: 설문 조사 [2] The largest share, 37.18 percent, said their children began using smartphones at 12 to 23 months old, while 13.8 percent said they started at 0 to 11 months. Combined, 50.

2026-10-11 17:53:16:00

HLB's liver cancer drug push gains momentum after first FDA approval

HLB’s first US approval for a cancer drug has given the Korean company fresh momentum in its effort to bring rivoceranib, a long-delayed liver cancer treatment, to market, as it seeks a green light from the US Food and Drug Administration after three failed attempts. The FDA approved Lyrfigtu, developed by HLB’s US subsidiary Elevar Therapeutics, for patients with previously treated advanced bile duct cancer harboring FGFR2 fusions or rearrangements on Sept. 23. The milestone gave Elevar Therape

2026-10-11 14:13:47:00

Samyang combines jjajangmyeon with beef tallow

Samyang Foods Chair Kim Jung-soo describes how the company injected the full flavor of jjajangmyeon, or black bean noodles, into Charrr, a pack of instant ramyeon, during a media event at the firm headquarters in Seoul on Wednesday. According to Samyang Foods, the new beef tallow product sold over 10 million units in the first 100 days of its launch while claiming second place on the list of most popular instant black bean noodles in Korea. The company said it expects 10 billion won in sales fro

2026-10-07 15:35:12:00